Brickell Biotech Financials

BBIDelisted Stock  USD 1.79  0.34  23.45%   
Based on the key indicators obtained from Brickell Biotech's historical financial statements, Brickell Biotech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
  
Understanding current and past Brickell Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brickell Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Brickell Biotech's assets may result in an increase in income on the income statement.

Brickell Biotech Stock Summary

Brickell Biotech competes with Southwest Airlines, Luxfer Holdings, Ryanair Holdings, Axalta Coating, and NL Industries. Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS10802T1051
Business Address5777 Central Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.brickellbio.com
Phone720 505 4755
CurrencyUSD - US Dollar

Brickell Biotech Key Financial Ratios

Brickell Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Brickell Biotech's current stock value. Our valuation model uses many indicators to compare Brickell Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brickell Biotech competition to find correlations between indicators driving Brickell Biotech's intrinsic value. More Info.
Brickell Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brickell Biotech's earnings, one of the primary drivers of an investment's value.

Brickell Biotech Market Pulse

 Quote1.79
 Change(%)  23.45 
 Change0.34 
 Open1.45
 Low1.42
 High1.98
 Volume0
 ExchangeNASDAQ

About Brickell Biotech Financials

What exactly are Brickell Biotech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Brickell Biotech's income statement, its balance sheet, and the statement of cash flows. Potential Brickell Biotech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Brickell Biotech investors may use each financial statement separately, they are all related. The changes in Brickell Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brickell Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Brickell Biotech December 1, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Brickell Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brickell Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brickell Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Brickell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brickell Biotech's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Brickell Stock

If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum